Zepbound® (tirzepatide) is a once-weekly injectable that mimics two hormones — GLP-1 and GIP — for powerful, dual-action weight loss. Prescribed online by licensed physicians and shipped to your door.
Brand-name tirzepatide · Once-weekly injectable
Zepbound® is the brand name for tirzepatide prescribed specifically for chronic weight management. It mimics two naturally occurring gut hormones — GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide). Together these hormones work on both the gut and the brain to regulate appetite and food intake.
Because Zepbound® targets two hormone pathways rather than one, it produces some of the largest average weight-loss results seen in clinical trials to date. It received FDA approval for weight management in adults with obesity, or who are overweight with at least one weight-related condition, in 2023.
Most weight-loss medications act on a single hormone. Zepbound® is first-of-its-kind because it mimics two — producing a combined effect on appetite and digestion.
By mimicking GLP-1, Zepbound® acts on hunger centers in the brain so you feel less hungry and more satisfied between meals.
It slows the rate at which your stomach empties, helping you feel full longer after eating and reducing the urge to snack.
The second hormone, GIP, complements GLP-1 to enhance the body's response — the dual effect linked to greater average weight loss.
Tirzepatide improves how the body manages blood sugar and insulin, supporting healthier metabolic markers alongside weight loss.
All Zepbound® formats are FDA-approved, available in the same doses, and have the same efficacy and side-effect profile. The difference is how they're delivered and how they're paid for.
A prefilled, single-use auto-injector pen containing one weekly dose. Simple click-and-inject design with no separate needle to manage — ideal for most patients getting started.
A single-dose vial administered with a separate needle and syringe. Shipped directly through LillyDirect® and typically the lowest-cost way to access brand-name Zepbound®.
The newest all-in-one prefilled auto-injector pen holding four weekly doses. Fewer devices to store and carry — a convenient option for established patients.
Your physician will recommend the right format based on your dose, budget, and insurance during your free evaluation.
Zepbound® is titrated slowly to help your body adjust and to minimize side effects. You start low and your physician increases the dose roughly every four weeks, as tolerated.
The 2.5 mg starting dose is for beginning treatment, not for ongoing weight management. Maintenance doses are 5 mg, 10 mg, or 15 mg. Not everyone reaches the maximum dose — your physician will find the lowest effective dose for you and may pause or adjust steps based on how you respond. Always follow your prescriber's instructions.
Zepbound® was studied in large, multi-week clinical trials. These are the headline results — individual outcomes vary.
In a 72-week trial (SURMOUNT-1) of the 15 mg dose, eligible patients without diabetes lost an average of about 21% of their body weight (roughly 48 lbs) when Zepbound® was combined with a reduced-calorie diet and increased physical activity.
Beyond weight management, the FDA has also approved Zepbound® to treat moderate to severe obstructive sleep apnea (OSA) in adults with obesity — making it the first medication of its kind cleared for this use.
* Based on the SURMOUNT-1 pivotal clinical trial. Results combine medication with diet and exercise. Individual results vary based on dose, adherence, and health history.
Zepbound® stands out as the only dual GLP-1 + GIP agonist approved for weight loss. Here's how it lines up against other common options.
| Feature | Zepbound® | Wegovy® | Saxenda® | Mounjaro® |
|---|---|---|---|---|
| Active ingredient | Tirzepatide | Semaglutide | Liraglutide | Tirzepatide |
| Drug class | GLP-1 + GIP dual | GLP-1 agonist | GLP-1 agonist | GLP-1 + GIP dual |
| Primary FDA use | Weight management | Weight management | Weight management | Type 2 diabetes |
| Administration | Weekly injection | Weekly injection | Daily injection | Weekly injection |
| Avg. weight loss | Up to ~21% | ~15% | ~8% | Up to ~21% |
| Also approved for | Sleep apnea (OSA) | Cardiovascular risk | Adolescents 12+ | Blood sugar control |
| Brand maker | Eli Lilly | Novo Nordisk | Novo Nordisk | Eli Lilly |
Average weight-loss figures are based on pivotal clinical trials and differ by medication, dose, and population. Your physician will recommend the most appropriate option for you.
There are two main paths to access Zepbound®. Our care team works directly with your insurer to help you navigate coverage wherever possible.
A prescription is only part of the picture. Your program wraps the medication in ongoing clinical care and support to help you succeed.
If you qualify, your physician prescribes Zepbound® in the format and dose that fits you.
Secure telemedicine evaluations and follow-ups with licensed providers — no waiting rooms.
Guidance on titration and managing common side effects, with a team you can message.
Coordinators check coverage, handle prior authorizations, and lay out cash-pay options.
Track weight, doses, and milestones so you and your provider can see what's working.
Medication ships from a licensed pharmacy directly to your door, refilled on schedule.
Our telemedicine process is fast, private, and designed to take you from consultation to prescription as smoothly as possible.
Tell us about your medical history and weight journey to see if you medically qualify — no cost, no obligation.
A licensed physician reviews your assessment, BMI, and goals via a secure telemedicine visit.
If Zepbound® is appropriate, your physician issues your prescription and chooses the right format and dose.
Your medication ships from a licensed pharmacy to your door, with ongoing monthly clinical support included.
Eligibility is always determined by a licensed physician during your clinical evaluation. These are the general guidelines.
Take the free quiz and our care team will help you understand your options — no commitment required.
Clinical trials paired the medication with diet and activity for a reason. These habits help protect muscle, ease side effects, and support lasting results.
Aim for protein at each meal to help preserve muscle while you lose fat, and to stay satisfied on a smaller appetite.
Combine regular movement with strength training. Resistance work is especially important for maintaining lean mass.
Plenty of water and fiber-rich foods help manage common digestive side effects like constipation.
Consistent, quality sleep supports appetite regulation and recovery — and complements the medication's effects.
Ongoing check-ins and community make the journey feel less isolating and help you stay consistent.
Build habits you can keep. Lasting results come from pairing medication with sustainable lifestyle change.
Most patients tolerate Zepbound® well. Side effects are typically mild, most common at the start of treatment or after dose increases, and improve as your body adjusts.
Most common at the start or after dose increases. Usually mild and eases within a few weeks. Smaller meals help.
Changes in GI motility are common. Staying hydrated and keeping up fiber intake helps manage symptoms.
Bloating, fullness, or mild abdominal pain — especially after eating. Typically resolves as your body adjusts.
An intended effect of the medication. Ensure you're still meeting your nutritional and protein needs.
Usually dose-related. Physicians titrate the dose gradually to minimize this. Report persistent symptoms.
Mild redness or swelling at the site. Rotating injection sites helps. Resolves quickly in most cases.
Rapid weight loss can raise gallstone risk. Report severe upper-abdominal pain, fever, or jaundice promptly.
Very rare but serious. Stop the medication and contact your physician immediately if you have severe, persistent abdominal pain.
Important: Zepbound® carries a boxed warning regarding the risk of thyroid C-cell tumors. This is a general overview and not a complete list of side effects or warnings. Your physician will review your full health history and explain all relevant risks during your evaluation. Always follow your physician's dosing instructions and report unusual symptoms promptly. Read full Important Safety Information →
A few simple practices keep your medication effective and your injections comfortable. Always follow the instructions that come with your prescription.
Store Zepbound® in the refrigerator until you're ready to use it. Do not freeze it — discard any medication that has frozen.
If needed, it can be kept at room temperature for a limited time per the label. Check your specific product's instructions.
Inject into the abdomen, thigh, or upper arm, rotating the site each week to reduce irritation. Inject on the same day weekly.
Place used pens, vials, and needles in an FDA-cleared sharps container — never loose in household trash.
If you miss a dose, take it within the allowed window per your instructions; otherwise skip it. Don't double up — ask your provider.
Reach your care team about severe or persistent side effects, signs of an allergic reaction, or questions about your dose.
Fast Medical Weight Loss pairs FDA-approved medication with real clinical oversight and a process built around you.
Every prescription is evaluated and issued by a licensed provider — never an automated checkout.
Nationwide telemedicine access, with visits conducted by secure video or questionnaire.
Medication ships from licensed pharmacies straight to your door in plain packaging.
Your health information is protected at every step of your care.
Clear cash-pay rates plus insurance support — no surprise fees, cancel anytime.
A care team for dosing questions, side effects, and refills throughout your journey.
No hidden fees. Cancel anytime. Cost varies by dose and format — your starting dose is the lowest price.
Clear answers to the most common questions about Zepbound®, tirzepatide, and our telemedicine program.
Both contain the same active ingredient, tirzepatide. Mounjaro® is FDA-approved for type 2 diabetes, while Zepbound® is FDA-approved specifically for chronic weight management (and, more recently, for obstructive sleep apnea).
Semaglutide targets one hormone receptor (GLP-1). Zepbound® targets two (GLP-1 and GIP). This dual action is linked to greater average weight loss in trials — up to ~21% versus ~15% — though the right choice depends on your health profile.
Single-dose pens are the most flexible and are insurance-eligible. Vials and the KwikPen® are cash-pay only, often at a lower price point. Your physician will recommend the best fit for your dose and budget.
Single-dose pens may be covered by commercial insurance, and our coordinators will work with your plan. Vials and the KwikPen® are cash-pay only. Government-sponsored plans typically require a cash-pay option.
Most patients notice reduced appetite within the first 1–2 weeks. Meaningful weight loss typically becomes visible at 4–8 weeks, with maximum results usually seen over 12–18 months of consistent treatment.
Research suggests many patients regain weight after stopping, since the medication controls hunger signals. That's why ongoing lifestyle changes alongside treatment matter — your physician will help build a long-term plan.
Zepbound® is most effective when combined with a reduced-calorie diet and increased physical activity — that's how it was studied in trials. Your physician will help you create a sustainable plan alongside the medication.
Evaluations are conducted via secure video or an asynchronous questionnaire, depending on your state and preference. All visits are HIPAA-compliant and conducted by licensed physicians.
Take the free quiz and let a licensed physician determine whether Zepbound® is right for your health profile, goals, and budget.
Start My Free ConsultationZepbound® and KwikPen® are registered trademarks of Eli Lilly and Company. This page has not been reviewed or endorsed by Eli Lilly and Company. *Average weight-loss figures are from the SURMOUNT-1 pivotal clinical trial (15 mg dose, 72 weeks) in eligible adults with a BMI ≥ 30, or ≥ 27 with weight-related comorbidities, combined with a reduced-calorie diet and increased physical activity. ‡Cash-pay Zepbound® pricing varies by dose and format; starting doses begin around $299/month and higher doses up to approximately $449/month. Pricing and availability are subject to change. Individual outcomes vary based on dose, adherence, diet, exercise, and health history. This page is for informational purposes only and does not constitute medical advice. All treatment requires a licensed physician evaluation, eligibility, and a prescription; not all patients will qualify. Prescriptions require an online consultation with a healthcare provider who will determine whether a prescription is appropriate. Medication is dispensed through licensed pharmacies, including LillyDirect®. ©2025 Fast Medical Weight Loss. HIPAA Compliant. All Rights Reserved.
©2026 All Rights Reserved. fastmedicalweightloss.org
